Delivery Order SPE2DB20D3103-SPE2DB25FM2J5

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.10 firm fixed-price contract is for the supply of 4566573084 - OXALIPLATIN 100 MG/20 ML VIAL 20ML, with a period of performance through December 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.00 firm fixed-price delivery order is for the supply of 100 mg/20 ml vials of the cancer treatment drug Oxaliplatin. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,160.00, is for the delivery of 4566286168 - Oxaliplatin 100 mg/20 mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4563957700 - OXALIPLATIN 50 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $1,486.48 and a completion date of March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
The Defense Logistics Agency awarded a $581 firm fixed price delivery order to Amerisourcebergen Drug Corporation for oxaliplatin injection. Under the contract, Amerisourcebergen will deliver 20 vials containing 100 milligrams of oxaliplatin per 20 milliliters to a facility in Conshohocken, Pennsylvania by June 21, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this oncology drug will likely support DOD medical treatment...
This is a $56,718.72 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers a wide range of medical products including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen...
This is a $76,959.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The award is associated with a larger $999,999,999 Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,322.21 firm fixed-price contract is for the supply of OxyContin ER 40 mg tablets, a prescription opioid medication. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This is a $57,418.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.96 fixed-price delivery order is for the supply of Oxaprozin 600 mg tablets, a pharmaceutical product. The contract has a period of performance through February 13, 2023 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2J5
    Delivery Order

This is a $2,160 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 mg/20 mL vials of the chemotherapy drug Oxaliplatin, a critical medical commodity supporting military healthcare programs.

This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, serving as a primary mechanism for providing a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare initiatives. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, further demonstrating the company's extensive federal contracting capabilities across the pharmaceutical and medical supply domains.

Generated 4/8/25, 9:55 AM